Viewing Study NCT02912793


Ignite Creation Date: 2025-12-25 @ 12:57 AM
Ignite Modification Date: 2026-01-03 @ 5:28 PM
Study NCT ID: NCT02912793
Status: COMPLETED
Last Update Posted: 2021-08-10
First Post: 2016-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients
Sponsor: Cyclo Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module